Literature DB >> 655282

Anticholinergic activity of two tricyclic antidepressants.

B Blackwell, A Stefopoulos, P Enders, R Kuzma, A Adolphe.   

Abstract

Using a double-blind crossover Latin square design, the authors evaluated the peripheral anticholinergic and central nervous system effects of three dose levels of two tricyclic antidepressants in female volunteers. Results showed that 5 hours after drug administration, desipramine (50 and 100 mg) caused significantly less reduction in salivation than did amitriptyline. Amitriptyline produced more sedation (Clyde Mood Scale) and a greater number of subjective complaints than did desipramine. These results are consistent with anticholinergic profiles from animal experiments and suggest that clinically meaningful differences may exist among tricyclic antidepressants.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 655282     DOI: 10.1176/ajp.135.6.722

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  14 in total

1.  Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants.

Authors:  H Bagheri; L Schmitt; M Berlan; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

2.  Yohimbine increases salivary secretion in depressed patients treated with tricyclic antidepressants.

Authors:  Y Rispail; L Schmitt; M Berlan; J L Montastruc; P Montastruc
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Binding affinities of four tricyclic antidepressive drugs to muscarinic cholinergic receptors in human parotid gland.

Authors:  S Batra; A Biörklund
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Effect of single oral doses of various neuroleptic drugs on salivary secretion rate, pH, and buffer capacity in healthy subjects.

Authors:  L Molander; D Birkhed
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers.

Authors:  W H Wilson; H Higano; Y Papadatos; S Kelwala; T A Ban
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

Review 6.  Adverse effects of antidepressant drugs. Part 2: 'Second generation' antidepressants and rational decision making in antidepressant therapy.

Authors:  B Blackwell
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546

7.  Effects of desipramine on irritable bowel syndrome compared with atropine and placebo.

Authors:  D S Greenbaum; J E Mayle; L E Vanegeren; J A Jerome; J W Mayor; R B Greenbaum; R W Matson; G E Stein; H A Dean; N A Halvorsen
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

8.  Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.

Authors:  H Bagheri; P Picault; L Schmitt; G Houin; M Berlan; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

9.  A comparison of the effects of single doses of amoxapine and amitriptyline on autonomic functions in healthy volunteers.

Authors:  M Bourne; E Szabadi; C M Bradshaw
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Tricyclic antidepressants and peripheral anticholinergic activity.

Authors:  S E Arnold; R J Kahn; L L Faldetta; R A Laing; D M McNair
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.